Hepatitis B treatment eligibility in West Africa: Uncertainties and need for prospective cohort studies

• Published in: Liver international Vol. 37; no. 8; pp. 1116 - 1121
• Main Authors: Jaquet, Antoine, Nouaman, Marcellin, Tine, Judicaël, Tanon, Aristophane, Anoma, Camille, Inwoley, André, Attia, Alain, Ekouevi, Didier K., Seydi, Moussa, Dabis, François, Wandeler, Gilles
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.08.2017
• Subjects: Adult; Africa; Africa, Western - epidemiology; Alanine; Alanine transaminase; Antiviral agents; antiviral treatment; Chronic infection; Cirrhosis; Cohort analysis; Cross-Sectional Studies; Female; Fibrosis; Hepatitis; Hepatitis B; Hepatitis B surface antigen; hepatitis B virus; Hepatitis B, Chronic - epidemiology; Humans; Liver; Liver cirrhosis; Male; Prevalence; Prisoners; Prisoners - statistics & numerical data; Prostitution; Replication; Sex Workers - statistics & numerical data; Sexual and Gender Minorities - statistics & numerical data; Therapy; Viruses; Workers; Ivory Coast; Togo; Senegal; West Africa; antiviral treatment; hepatitis B virus; Africa

Background & Aims While universal screening of hepatitis B virus (HBV) is recommended in high burden countries, little is known about the proportion of HBV‐infected persons in need of antiviral therapy in these settings. Methods Prisoners in Senegal and Togo as well as female sex workers and men...